PQ 1651
1651. Deputy Brendan Smith asked the Minister for Health further to Parliamentary Question No. 197 of 21 June 2018, if there have been further developments in regard to the availability through the HSE of the drug Pembrolizumab in view of its potential benefits to patients; and if he will make a statement on the matter. [33964/18]
Introduced
24 July 2018
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
24 July 2018
Summary
1651. Deputy Brendan Smith asked the Minister for Health further to Parliamentary Question No. 197 of 21 June 2018, if there have been further developments in regard to the availability through the HSE of the drug Pembrolizumab in view of its potential benefits to patients; and if he will make a statement on the matter. [33964/18]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 24 July 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2018-07-24/1651/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2018-07-24/pq_1651